Ferlitsch A, Kummer F, Müller M M, Legenstein E, Haber P, Kohout J
Acta Med Austriaca. 1978;5(4-5):171-4.
Serum angiotensin converting enzyme (ACE) activity was studied in 50 patients with sarcoidosis (39 active, 11 inactive sarcoidosis), as well as in 50 control patients (34 chronic lung diseases, 9 Hodgkin-disease, 7 rheumatoid arthritis). There is a significant difference (p less than 0.001) of ACE-activity between sarcoidosis patients and controls, and between active (without steroid treatment) and inactive sarcoidosis. Steroid treatment apparently lowers ACE-activity in sarcoidosis, however, without evidence for clinical improvement. Increased ACE-activity was also found in a patient with primary biliary cirrhosis.
对50例结节病患者（39例活动期、11例非活动期结节病）以及50例对照患者（34例慢性肺部疾病、9例霍奇金病、7例类风湿关节炎）的血清血管紧张素转换酶（ACE）活性进行了研究。结节病患者与对照患者之间，以及活动期（未接受类固醇治疗）与非活动期结节病患者之间的ACE活性存在显著差异（p<0.001）。类固醇治疗显然会降低结节病患者的ACE活性，然而，并无临床改善的证据。在一名原发性胆汁性肝硬化患者中也发现了ACE活性升高。
